Skip to Main Content
An official website of the United States government

CA-125 Velocity

Principal Investigator

Name
Jian-Lun Xu

Institution
NCI, DCP, BRG

Email
jianxu@helix.nih.gov

About this CDAS Project

Study
PLCO (Learn more about this study)

Project ID
2006-0043

Initial CDAS Request Approval
Jul 1, 2006

Title
CA-125 Velocity

Summary
Biomarker such as CA125 usually provides an inexpensive noninvasive approach to cancer screening. The low background levels in healthy people are usually stable over time, while biomarker levels in patients with asymptomatic disease can behave differentially. Changes in a biomarker over time have been recognized as providing additional information, but only ad hoc. Rules have been suggested for measuring this information and incorporating it into the strategy. This study will model changes of biomarker over time and use the new model to predict the probability of having ovarian cancer.

Aims

Specific aims of the proposal are (i) to introduce a new model for the changes of biomarker over time which will generalize the available models, (ii) to use the new model to predict the probability of having ovarian cancer, and (iii) to apply the new model to ovarian cancer as well as prostate cancer in PLCO trial.

Related Publications